Cargando…

Assessment of biorisk management systems in high containment laboratories, 18 countries in Europe, 2016 and 2017

Europe-wide activities to improve biosafety and biosecurity performed within the frameworks of the European Union (EU)-funded Joint Actions EMERGE and QUANDHIP led to the development of an Integrated European Checklist for Laboratory Biorisk Management (ECL). To better understand different approache...

Descripción completa

Detalles Bibliográficos
Autores principales: Appelt, Sandra, Jacob, Daniela, Rohleder, Anna-Maria, Bråve, Andreas, Szekely Björndal, Åsa, Di Caro, Antonino, Grunow, Roland
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Centre for Disease Prevention and Control (ECDC) 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7502897/
https://www.ncbi.nlm.nih.gov/pubmed/32914748
http://dx.doi.org/10.2807/1560-7917.ES.2020.25.36.2000089
_version_ 1783584283540062208
author Appelt, Sandra
Jacob, Daniela
Rohleder, Anna-Maria
Bråve, Andreas
Szekely Björndal, Åsa
Di Caro, Antonino
Grunow, Roland
author_facet Appelt, Sandra
Jacob, Daniela
Rohleder, Anna-Maria
Bråve, Andreas
Szekely Björndal, Åsa
Di Caro, Antonino
Grunow, Roland
author_sort Appelt, Sandra
collection PubMed
description Europe-wide activities to improve biosafety and biosecurity performed within the frameworks of the European Union (EU)-funded Joint Actions EMERGE and QUANDHIP led to the development of an Integrated European Checklist for Laboratory Biorisk Management (ECL). To better understand different approaches shaping biorisk management (BRM) systems on an operational level in high containment laboratories, the ECL was used to map the implementation of BRM in 32 high containment laboratories in 18 countries in Europe. The results suggest that the BRM elements referring to standard microbiological working practices and the handling of infectious material were fulfilled particularly well. The elements safety exercises involving internal and external emergency responders, and appropriate decommissioning plans were not fulfilled particularly well. BRM in Biosafety Level (BSL) 4 laboratories handling Risk Group (RG) 4 viruses appear to vary among each other less than BSL3 laboratories handling RG 3 bacteria. It is important to agree on comparable regulations in Europe as high containment laboratories are indispensable for a safe, quick and effective response to public health threats. As high containment laboratories may also present a public health risk it is crucial to have robust BRM on organisational and operational levels.
format Online
Article
Text
id pubmed-7502897
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher European Centre for Disease Prevention and Control (ECDC)
record_format MEDLINE/PubMed
spelling pubmed-75028972020-09-28 Assessment of biorisk management systems in high containment laboratories, 18 countries in Europe, 2016 and 2017 Appelt, Sandra Jacob, Daniela Rohleder, Anna-Maria Bråve, Andreas Szekely Björndal, Åsa Di Caro, Antonino Grunow, Roland Euro Surveill Perspective Europe-wide activities to improve biosafety and biosecurity performed within the frameworks of the European Union (EU)-funded Joint Actions EMERGE and QUANDHIP led to the development of an Integrated European Checklist for Laboratory Biorisk Management (ECL). To better understand different approaches shaping biorisk management (BRM) systems on an operational level in high containment laboratories, the ECL was used to map the implementation of BRM in 32 high containment laboratories in 18 countries in Europe. The results suggest that the BRM elements referring to standard microbiological working practices and the handling of infectious material were fulfilled particularly well. The elements safety exercises involving internal and external emergency responders, and appropriate decommissioning plans were not fulfilled particularly well. BRM in Biosafety Level (BSL) 4 laboratories handling Risk Group (RG) 4 viruses appear to vary among each other less than BSL3 laboratories handling RG 3 bacteria. It is important to agree on comparable regulations in Europe as high containment laboratories are indispensable for a safe, quick and effective response to public health threats. As high containment laboratories may also present a public health risk it is crucial to have robust BRM on organisational and operational levels. European Centre for Disease Prevention and Control (ECDC) 2020-09-10 /pmc/articles/PMC7502897/ /pubmed/32914748 http://dx.doi.org/10.2807/1560-7917.ES.2020.25.36.2000089 Text en This article is copyright of the authors or their affiliated institutions, 2020. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution (CC BY 4.0) Licence. You may share and adapt the material, but must give appropriate credit to the source, provide a link to the licence, and indicate if changes were made.
spellingShingle Perspective
Appelt, Sandra
Jacob, Daniela
Rohleder, Anna-Maria
Bråve, Andreas
Szekely Björndal, Åsa
Di Caro, Antonino
Grunow, Roland
Assessment of biorisk management systems in high containment laboratories, 18 countries in Europe, 2016 and 2017
title Assessment of biorisk management systems in high containment laboratories, 18 countries in Europe, 2016 and 2017
title_full Assessment of biorisk management systems in high containment laboratories, 18 countries in Europe, 2016 and 2017
title_fullStr Assessment of biorisk management systems in high containment laboratories, 18 countries in Europe, 2016 and 2017
title_full_unstemmed Assessment of biorisk management systems in high containment laboratories, 18 countries in Europe, 2016 and 2017
title_short Assessment of biorisk management systems in high containment laboratories, 18 countries in Europe, 2016 and 2017
title_sort assessment of biorisk management systems in high containment laboratories, 18 countries in europe, 2016 and 2017
topic Perspective
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7502897/
https://www.ncbi.nlm.nih.gov/pubmed/32914748
http://dx.doi.org/10.2807/1560-7917.ES.2020.25.36.2000089
work_keys_str_mv AT appeltsandra assessmentofbioriskmanagementsystemsinhighcontainmentlaboratories18countriesineurope2016and2017
AT jacobdaniela assessmentofbioriskmanagementsystemsinhighcontainmentlaboratories18countriesineurope2016and2017
AT rohlederannamaria assessmentofbioriskmanagementsystemsinhighcontainmentlaboratories18countriesineurope2016and2017
AT braveandreas assessmentofbioriskmanagementsystemsinhighcontainmentlaboratories18countriesineurope2016and2017
AT szekelybjorndalasa assessmentofbioriskmanagementsystemsinhighcontainmentlaboratories18countriesineurope2016and2017
AT dicaroantonino assessmentofbioriskmanagementsystemsinhighcontainmentlaboratories18countriesineurope2016and2017
AT grunowroland assessmentofbioriskmanagementsystemsinhighcontainmentlaboratories18countriesineurope2016and2017
AT assessmentofbioriskmanagementsystemsinhighcontainmentlaboratories18countriesineurope2016and2017